Cost-Related Medication Nonadherence Among Beneficiaries With Depression Following Medicare Part D

被引:33
|
作者
Zivin, Kara [1 ]
Madden, Jeanne M. [2 ,3 ]
Graves, Amy J. [2 ,3 ]
Zhang, Fang [2 ,3 ]
Soumerai, Stephen B. [2 ,3 ]
机构
[1] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA
[2] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA
[3] Harvard Pilgrim Hlth Care, Boston, MA USA
来源
基金
美国医疗保健研究与质量局;
关键词
Depression; medicare part D; cost-related nonadherence to medications; ANTIDEPRESSANT TREATMENT; PRIOR AUTHORIZATION; ADHERENCE; KNOWLEDGE; BENEFITS; PEOPLE; IMPACT;
D O I
10.1097/JGP.0b013e3181b972d1
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Context: Cost-related medication nonadherence (CRN) was problematic for Medicare beneficiaries with depressive symptoms before Medicare Part D. Objective: To estimate changes in CRN and forgoing basic needs to pay for drugs among Medicare beneficiaries with and without depressive symptoms following Part D implementation. Design and Setting: The authors compared changes in outcomes between 2005 and 2006 before and after Part D with changes between 2004 and 2005 using logistic regression to control for demographic characteristics, health status, and historical trends. Participants: The community-dwelling sample of the Medicare Current Beneficiary Survey (N = 24,234). Main Outcome Measures: Self-reports of CRN (skipping or reducing doses and not obtaining prescriptions) and spending less on basic needs to afford medicines. Results: The unadjusted annual prevalence of CRN among beneficiaries with depressive symptoms was 27% (2004), 27% (2005), and 24% (2006), compared with 13%, 12%, and 9% among beneficiaries without depressive symptoms. The annual prevalence of spending less on basic needs was 22% (2004), 23% (2005), and 19% (2006), compared with 8%, 9%, and 5% among beneficiaries without depressive symptoms. Controlling for historical changes and demographic characteristics, CRN did not decline among beneficiaries with depressive symptoms compared with beneficiaries without depressive symptoms (ratio of Part D changes 0.98; 95% confidence interval [CI], 0.73-1.32). Respondents with depressive symptoms seemed less likely to spend less on basic needs compared with individuals without depressive symptoms (0.70; 95% CI, 0.49-1.01); however, this difference was not statistically significant. Conclusions: Despite a Medicare Part D goal to improve medication adherence among mentally ill beneficiaries, the disparity in economic access to medications between beneficiaries with and without depressive symptoms did not improve after the start of Part D. (Am J Geriatr Psychiatry 2009;17:1068-1076)
引用
收藏
页码:1068 / 1076
页数:9
相关论文
共 50 条
  • [21] Cancer history, insurance coverage, and cost-related medication nonadherence in Medicare beneficiaries, 2013-2018
    Li, Meng
    Bounthavong, Mark
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (12): : 1750 - 1756
  • [22] Cost-related medication nonadherence among Medicare beneficiaries with cardiovascular disease risk factors: The role of comprehension of the Medicare programme and its prescription drug benefits
    Park, Chanhyun
    Chang, Chiu-chi Angela
    Ng, Boon Peng
    Young, Gary J.
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2023, 29 (01) : 136 - 145
  • [23] Racial/Ethnic Differences in Cost-Related Nonadherence and Medicare Part D: A Longitudinal Comparison
    Bakk, Louanne
    [J]. JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2015, 26 (04) : 1132 - 1148
  • [24] A DIFFERENTIAL DIAGNOSIS OF COST-RELATED MEDICATION NONADHERENCE
    Sohn, Natalie
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S604 - S604
  • [25] Cost-related medication nonadherence among elderly emergency department patients
    Johnson, Riley
    Harmon, Rochelle
    Klammer, Catherine
    Kumar, Anjana
    Greer, Conner
    Beasley, Kyle
    Wigstadt, Stephanie
    Ambrose, Lisa
    Vandepol, Eric
    Jones, Jeffrey
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2019, 37 (12): : 2255 - 2256
  • [26] Cost-Related Medication Nonadherence (CRN) on Healthcare Utilization and Patient-Reported Outcomes: Considerations in Managing Medicare Beneficiaries on Antidepressants
    Alnijadi, Abdulrahman A.
    Yuan, Jing
    Wu, Jun
    Li, Minghui
    Lu, Z. Kevin
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [27] Risk for Cost-related Medication Nonadherence Among Emergency Department Patients
    Mazer, Maryann
    Bisgaier, Joanna
    Dailey, Elizabeth
    Srivastava, Kavita
    McDermoth, Monique
    Datner, Elizabeth
    Rhodes, Karin V.
    [J]. ACADEMIC EMERGENCY MEDICINE, 2011, 18 (03) : 267 - 272
  • [28] Drug Costs in Medicare Dollars and Cost-Related Nonadherence
    Zagaria, Mary Ann E.
    [J]. US PHARMACIST, 2019, 44 (06) : 8 - +
  • [29] The Role of Gender in Cost-Related Medication Nonadherence Among Patients with Diabetes
    Bhuyan, Soumitra S.
    Shiyanbola, Olayinka
    Deka, Pallav
    Isehunwa, Oluwaseyi O.
    Chandak, Aastha
    Huang, Sean
    Wang, Yang
    Bhatt, Jay
    Ning, Lu
    Lin, Wang Jun
    Wyant, David
    Kedia, Satish
    Chang, Cyril F.
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2018, 31 (05) : 743 - 751
  • [30] Cost-Related Immunosuppressive Medication Nonadherence Among Kidney Transplant Recipients
    Evans, Roger W.
    Applegate, William H.
    Briscoe, David M.
    Cohen, David J.
    Rorick, Christopher C.
    Murphy, Barbara T.
    Madsen, Joren C.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (12): : 2323 - 2328